scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1423-0410.1999.7710024.X |
P698 | PubMed publication ID | 10474087 |
P2093 | author name string | Despotis GJ | |
Goodnough LT | |||
Spitznagel E | |||
Dynis M | |||
Baorto D | |||
P2860 | cites work | Frequency of immediate adverse effects associated with apheresis donation | Q33175808 |
Complications of plasma exchange | Q38517393 | ||
Biomaterials for blood-contacting applications | Q40647756 | ||
Detection of plasmapheresis-induced platelet activation using monoclonal antibodies | Q46876930 | ||
Differential induction of P-selectin expression on platelets by two cell separators during plateletpheresis and the effect of gender on the release of soluble P-selectin. | Q50905712 | ||
P433 | issue | 1 | |
P921 | main subject | multivariate statistics | Q1952580 |
P304 | page(s) | 24-32 | |
P577 | publication date | 1999-01-01 | |
P1433 | published in | Vox Sanguinis | Q15708866 |
P1476 | title | Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program | |
P478 | volume | 77 |
Q37542963 | A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India |
Q53508615 | Adverse Events During Apheresis Procedures: Audit at a Tertiary Hospital. |
Q36732672 | Adverse events associated with apheresis procedures: Incidence and relative frequency |
Q33157104 | Adverse reactions during voluntary donation of blood and/or blood components. A statistical-epidemiological study |
Q33157218 | Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres |
Q80521847 | Arteriovenous fistula formation in a volunteer allogeneic peripheral blood progenitor cell donor |
Q30252024 | Citrate anticoagulation: Are blood donors donating bone? |
Q34790959 | Comparison of Plateletpheresis on the Fenwal Amicus and Fresenius Com.Tec Cell Separators. |
Q37589285 | Consensus and controversies in platelet transfusion |
Q45121544 | Discontinuous automated calcium supplementation during thrombocytapheresis with the MCS+ version C. Absence of severe complication due to calcium deprivation in 4308 procedures |
Q33805801 | Donor Safety in Haemapheresis: Development of an Internet-Based Registry for Comprehensive Assessment of Adverse Events from Healthy Donors. |
Q30971646 | Donor vigilance data of a blood transfusion service: A multicenter analysis |
Q46426136 | Effect of thrombocytapheresis on blood rheology in healthy donors: role of nitric oxide |
Q85962044 | Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia |
Q33163008 | Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India. |
Q92759964 | Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors |
Q33152691 | Incidents of blood donation |
Q33361167 | Optimizing platelet transfusion therapy |
Q73775002 | Platelet transfusion therapy |
Q33148196 | QTc prolongation in apheresis platelet donors |
Q33164521 | Risk factors associated with the occurrence of adverse events in plateletpheresis donation |
Q34762323 | Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections |
Q33159415 | Serious adverse effects of blood collection |
Q33690874 | Single-donor platelet apheresis: observational comparison of the new Haemonetics Universal Platelet protocol with the previous Concentrated Single Donor Platelet protocol |
Q50515460 | Switching iron-deficient whole blood donors to plateletpheresis. |
Q81548338 | The effects of plateletpheresis on donor platelet function and coagulation |
Q53544180 | The effects of warming methods on temperature, cardiac function and cytokines in plateletpheresis donors. |
Q38371628 | The role of thrombocytapheresis in the contemporary management of hyperthrombocytosis in myeloproliferative neoplasms: A case-based review. |
Q62090516 | Transfusión de plaquetas, ¿concentrados procedentes de un único o de múltiples donantes? |
Q36458599 | Unique donor-suitability issues |
Q48283895 | Vasovagal reactions in blood donors: risks, prevention and management |
Q36287344 | What's happening: an overview of potential adverse reactions associated with apheresis technology |
Search more.